Levels of an antibody found in recovered COVID-19 patients fell sharply in the two to three months after infection for both symptomatic and asymptomatic patients, according to a Chinese study, raising questions about the length of any immunity against the novel coronavirus.
The research, published in Nature Medicine on June 18, highlights the risks of using COVID-19 "immunity passports" and supports the prolonged use of public health interventions such as social distancing and isolating high-risk groups, researchers said.
Health authorities in some countries such as Germany are debating the ethics and practicalities of allowing people who test positive for antibodies to move more freely than others who don't.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.